Axsome Therapeutics
AXSM
AXSM
346 hedge funds and large institutions have $3.95B invested in Axsome Therapeutics in 2025 Q2 according to their latest regulatory filings, with 56 funds opening new positions, 152 increasing their positions, 89 reducing their positions, and 57 closing their positions.
New
Increased
Maintained
Reduced
Closed
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more ownership
Funds ownership: →
less first-time investments, than exits
New positions opened: | Existing positions closed:
less call options, than puts
Call options by funds: $ | Put options by funds: $
1% less funds holding
Funds holding: 350 → 346 (-4)
8% less capital invested
Capital invested by funds: $4.32B → $3.95B (-$365M)
42% less funds holding in top 10
Funds holding in top 10: 12 → 7 (-5)
Holders
346
Holding in Top 10
7
Calls
$66.7M
Puts
$69.3M
Top Buyers
| 1 | +$84.9M | |
| 2 | +$61.5M | |
| 3 | +$42.2M | |
| 4 |
HRCM
Hood River Capital Management
Palm Beach Gardens,
Florida
|
+$39.3M |
| 5 |
BlackRock
New York
|
+$32.9M |
Top Sellers
| 1 | -$149M | |
| 2 | -$47.3M | |
| 3 | -$42.4M | |
| 4 |
D.E. Shaw & Co
New York
|
-$36.7M |
| 5 |
Invesco
Atlanta,
Georgia
|
-$30.2M |